在2024年11月7日盘前交易中,Guardant Health Inc.(股票代码:GH)股价大涨16.65%,原因得归功于分析师近期对该公司的利好评级和目标价上调。
路透汇总的分析师评级调整显示,多家机构看好Guardant Health的前景。其中,摩根大通将其目标价从48美元上调至50美元;而Leerink Partners将目标价从50美元上调至60美元,评级更为乐观。
分析师对Guardant Health前景看好的主要原因是,该公司在液体活检等创新医疗检测领域处于领先地位,预计未来几年将获得长足发展。随着新冠疫情的影响逐步减弱,液体活检等医疗服务的需求有望大幅提升,Guardant Health将从中获益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.